Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Wang, Pei  [Clear All Filters]
Journal Article
Zeng W, Xiong L, Wu W, Li S, Liu J, Yang L, Lao L, Huang P, Zhang M, Chen H, et al. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. Oncogene. 2022.
Wang P, Peng Z, Zhang Y, Zhang X, Chen X, Li F, Chen B, Niu S, Du K, Zhu L-M. A chitosan-camouflaged nanomedicine triggered by hierarchically stimuli to release drug for multimodal imaging-guided chemotherapy of breast cancer. Carbohydr Polym. 2024;335:122073.
Sebastiano V, Zhen HHui, Derafshi BHaddad, Bashkirova E, Melo SP, Wang P, Leung TL, Siprashvili Z, Tichy A, Li J, et al. Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2014;6(264):264ra163.
Wang H, Luo X, Yao L, Lehman D, Wang P. Improvement of Cell Survival during Human Pluripotent Stem Cell Definitive Endoderm Differentiation. Stem Cells Dev. 2015.
Dou R, Zhang X, Xu X, Wang P, Yan B. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization. Mol Immunol. 2021;139:106-114.
Guo Q, Zhao C, Gao X, Ding L, Wang P, Ren Y'nan, Hou X, Yao Y, Zhang C, Yang X, et al. One-Minute Iodine Isotope Labeling Technology Enables Noninvasive Tracking and Quantification of Extracellular Vesicles in Tumor Lesions and Intact Animals. Mol Pharm. 2023.